Copeland Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CEB
CEB Inc.
CEB
|
+$24M |
| 2 |
L3Harris
LHX
|
+$23.6M |
| 3 |
Broadridge
BR
|
+$23.1M |
| 4 |
Broadcom
AVGO
|
+$22.5M |
| 5 |
CWEN.A
Clearway Energy Class A
CWEN.A
|
+$21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$21.4M |
| 2 |
Baxter International
BAX
|
+$17.7M |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$14.3M |
| 4 |
Blackrock
BLK
|
+$14M |
| 5 |
VF Corp
VFC
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 17.39% |
| 2 | Consumer Discretionary | 14.13% |
| 3 | Healthcare | 13.04% |
| 4 | Financials | 12.18% |
| 5 | Technology | 7.62% |
Similar funds
Copeland Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Copeland Capital Management held 208 positions worth $1.95B, up 30% from $1.51B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Copeland Capital Management deployed $495M of net new capital in Q2 2015, opening 15 new positions and adding to 121 existing holdings. Its largest new stake was Broadcom: 1,720,870 shares worth $22.9M.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Novo Nordisk, an estimated $21.4M trimmed.
- Copeland Capital Management's largest Q2 2015 buy was Broadcom: 1,720,870 shares worth $22.9M.
- Copeland Capital Management added most to CEB Inc. in Q2 2015, an estimated $24M increase.
- Copeland Capital Management's biggest Q2 2015 reduction was Novo Nordisk, cutting an estimated $21.4M.
- Copeland Capital Management fully exited Baxter International in Q2 2015, selling an estimated $17.7M.
- Copeland Capital Management's ten largest holdings make up 18% of its $1.95B portfolio in Q2 2015.
- Copeland Capital Management opened 15 new positions and closed 20 in Q2 2015.
- Copeland Capital Management's portfolio value rose 30% quarter-over-quarter to $1.95B.
Based on Copeland Capital Management's 13F filing for Q2 2015, filed 6 Aug 2015.